The Bulletin
The Times


.

AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine

  • Written by The Bulletin

Achieve quality upgrade of traditional human diploid wild seedlings

HONG KONG SAR - Media OutReach Newswire - 27 March 2024 - AIM Vaccine Co., Ltd. (the "AIM Vaccine", together with its subsidiaries, the "Group") is pleased to announce that the Group has submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine on March 24, 2024.

Read more: AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective...

hacklink hack forum hacklink film izle hacklink online casinos australiaonwinonline casino australiaroyalbet girişjojobetPalazzobetcratosroyalbetbandar bolanon gamstop casinosonline casinosonline casinovedonlyöntimaailmaonline casinos australiaaustralian online casinosroyal reelsroyal reelsroyal reels casino australiaroyalreels.pokerroyal reels casinojojobetthe pokies net onlinez_libraryjojobetสล็อตสล็อตroyal reels casinojojobetjojobetstakeholiganbetnakitbahisjojobetcasibomjojobet